Corporate DisclosureJMISMDL
JMISMDL Corporate Disclosure — 14 June 2020
Announcement summary
- What happened
- JMISMDL published a corporate disclosure on 14 June 2020. Read the full announcement for details.
- Company
- JMI Syringes & Medical Devices Ltd.
- Announcement published
Original announcement
The Company has informed that the Board of Directors has approved the valuation report based on the statement of the financial position as at June 30, 2019 of the following categories of Fixed Assets i) Land and land development, ii) Factory building and other construction. The amount of Fixed Assets has been increased from Tk. 62,05,89,304.00 to Tk. 72,24,64,882.00. Revaluation surplus was Tk. 10,18,75,578.00. They also informed that after revaluation, NAV per share would be Tk. 121.15.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b000040057034
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from JMISMDL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.